-
14641por Nguyen, Hao T., Pham, Nhi T. U., Tran, Tu N. A., Nguyen, Nhuong T. T., Vu, Thao T. P.“…The effectiveness of secukinumab was validated in subgroups of patients with or without obesity, concomitant conditions (hepatitis B virus, hepatitis C virus, diabetes, high blood pressure, gout, and/or obesity [body mass index ≥ 30 kg/m(2)]), and concomitant psoriatic arthritis (PsA). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14642“…BACKGROUND: To investigate the predictive values of cytokeratin 18 for liver fibrosis in hepatitis C virus (HCV) infected patients with type 2 diabetes mellitus (T2DM). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14643por Zhang, Yuan, Hu, Xing, Chang, Jing, Chen, Jie, Han, Xue, Zhang, Tieying, Shen, Jianjun, Shang, Ning, Han, Jing, Wang, Hui, Kang, Weiwei, Meng, Fankun“…METHODS: We retrospectively analyzed 479 cases of PBC, chronic hepatitis B (CHB), chronic hepatitis C (CHC), non-alcoholic fatty liver disease (NAFLD), and healthy subjects (Normal) diagnosed by liver biopsy or definitive clinical diagnosis. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14644“…Medical records and patients’ oral information regarding substance use, OST medication or hepatitis C infection were identified as circumstances bringing unwanted attention to the SUD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14645por Duret, Amedine, Thorley, Emma, Eni-Olotu, Ayolola, Sikdar, Oishi, Papineni, Padmasayee“…The UK prevalence of hepatitis B virus (HBV) is 0.1-0.5% and for hepatitis C virus (HCV) is 0.5-1%. Chronic infection with HBV or HCV can lead to an increased risk of adverse treatment outcomes, such as drug-induced liver injury (DILI) in patients with active or latent TB. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14646por Ho, Minh Q, Dinges, Elizabeth, Slazinski, Karen, Byrd, Jacqueline, Ahmed, Mohammed“…BACKGROUND: Syringe Services Programs (SSPs) is one aspect of a comprehensive Harm Reduction approach necessary to reduce the transmission of blood borne infections including Hepatitis B, Hepatitis C, and HIV. Substance Abuse and Mental Health Services Administration (SAMHSA) estimates that in 2019 that 595,000 veterans engage in opioid misuse with at least 57,000 veterans engaging in heroin. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14647“…BACKGROUND: The province of Saskatchewan has had the highest rates of HIV and Hepatitis C in Canada for over 10 years, the majority of which is related to People who inject drugs (PWID) and with higher proportion of young women. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14648por Wang, Zhanwei, Budhu, Anuradha S, Shen, Yi, Wong, Linda Lou, Hernandez, Brenda Y, Tiirikainen, Maarit, Ma, Xiaomei, Irwin, Melinda L, Lu, Lingeng, Zhao, Hongyu, Lim, Joseph K, Taddei, Tamar, Mishra, Lopa, Pawlish, Karen, Stroup, Antoinette, Brown, Robert, Nguyen, Mindie H, Koshiol, Jill, Hernandez, Maria O, Forgues, Marshonna, Yang, Hwai‐I, Lee, Mei‐Hsuan, Huang, Yu‐Han, Iwasaki, Motoki, Goto, Atsushi, Suzuki, Shiori, Matsuda, Koichi, Tanikawa, Chizu, Kamatani, Yoichiro, Mann, Dean, Guarnera, Maria, Shetty, Kirti, Thomas, Claire E, Yuan, Jian‐Min, Khor, Chiea Chuen, Koh, Woon‐Puay, Risch, Harvey, Wang, Xin Wei, Yu, Herbert“…BACKGROUND AND AIM: Chronic hepatitis C virus (HCV) infection, long‐term alcohol use, cigarette smoking, and obesity are the major risk factors for hepatocellular carcinoma (HCC) in the United States, but the disease risk varies substantially among individuals with these factors, suggesting host susceptibility to and gene–environment interactions in HCC. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14649por Shankaran, Veena, Chennupati, Shasank, Sanchez, Hayley, Sun, Qin, Li, Li, Fedorenko, Catherine, Aly, Abdalla, Healey, Marcus, Seal, Brian“…RESULTS: The final cohort included 215 patients, the majority of whom were white (71%), male (68%), and with underlying hepatitis C (61%). Mean per patient lifetime costs were highest in BCLC A and BCLC C patients. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14650por Maqsood, Sidra, Iqbal, Sarosh, Zakar, Rubeena, Zakar, Muhammad Zakria, Fischer, Florian“…BACKGROUND: In 2019, around 5 million and 10 million people were affected by hepatitis B virus (HBV) and hepatitis C virus (HCV) respectively in Pakistan. On World Hepatitis Day 2019, Pakistan’s Government announced the Prime Minister’s Plan to eliminate HBV and HCV from the country by 2030. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14651por Fadanelli, Monica, Cooper, Hannah L. F., Freeman, Patricia R., Ballard, April M., Ibragimov, Umed, Young, April M.“…Anti-stigma education about substance use disorder (SUD), human immunodeficiency virus (HIV), and Hepatitis C (HCV) is likely needed to truly shift restrictive pharmacy policy.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14652por Hamdane, Nourdine, Jühling, Frank, Crouchet, Emilie, El Saghire, Houssein, Thumann, Christine, Oudot, Marine A., Bandiera, Simonetta, Saviano, Antonio, Ponsolles, Clara, Suarez, Armando Andres Roca, Li, Shen, Fujiwara, Naoto, Ono, Atsushi, Davidson, Irwin, Bardeesy, Nabeel, Schmidl, Christian, Bock, Christoph, Schuster, Catherine, Lupberger, Joachim, Habersetzer, François, Doffoël, Michel, Piardi, Tullio, Sommacale, Daniele, Imamura, Michio, Uchida, Takuro, Ohdan, Hideki, Aikata, Hiroshi, Chayama, Kazuaki, Boldanova, Tujana, Pessaux, Patrick, Fuchs, Bryan C., Hoshida, Yujin, Zeisel, Mirjam B., Duong, François H. T., Baumert, Thomas F.“…BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatocellular carcinoma (HCC). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14653por Wu, Hui-Chen, Jeng, Wen-Juei, Pan, Mei-Hung, Hsieh, Yi-Chung, Lu, Sheng-Nan, Chen, Chien-Jen, Yang, Hwai-I.“…Prevention and treatment of diabetes and heart disease are critical for non-hepatitis B, non-hepatitis C (NonB/C)-HCC. LAY SUMMARY: We followed up individuals with no chronic HBV or HCV infection and described the risk of hepatocellular carcinoma (HCC, the most common form of primary liver cancer) and mortality from liver-related disease by modifiable risk factors. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14654por Jiménez-Mendoza, JC, Rivera-López, FE, González-Lara, MF, Valdez-Echeverría, RD, Castro-Narro, GE, Tore, A, Uscanga-Domínguez, LF, Moctezuma-Velázquez, C“…The high number of COVID-19 hospitalizations represent a great opportunity to screen patients for hepatitis B virus (HBV) and hepatitis C virus (HCV), which was the aim of this study. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14655por Stoffers, Philipp, Guckenbiehl, Sabrina, Welker, Martin Walter, Zeuzem, Stefan, Lange, Christian Markus, Trebicka, Jonel, Herrmann, Eva, Welsch, Christoph“…RESULTS: In this cohort study, 80 patients (50%) were diagnosed with alcoholic liver cirrhosis, 60 patients (37.5%) with hepatitis C virus- and 20 patients (13.5%) with hepatitis B virus-related liver cirrhosis. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14656por Shimizu, Tomo, Sawada, Takashi, Asai, Tomohide, Kanetsuki, Yuka, Hirota, Jiro, Moriguchi, Michihisa, Nakajima, Tomoaki, Miyazaki, Toru, Okanoue, Takeshi“…METHODS: IgM-free AIM levels were measured in 212 serum samples from patients with, or without, HCC related to NASH, hepatitis B virus, and hepatitis C virus, using ECLIA. We also developed an ECLIA for measuring both IgM-free and IgM-bound AIM and investigated the existing form of AIM in blood by size-exclusion chromatography. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14657“…Adult patients with cirrhosis 2000/01/01-2017/12/31 were identified and etiology of liver disease was assigned as hepatitis C (HCV), hepatitis B (HBV), alcohol-associated liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), or autoimmune liver disease (AI)/other using validated algorithms for cirrhosis (sensitivity [sn] 99%, specificity [sp] 79%) and cirrhosis etiology (sn 75%-97%, sp 95%-100%). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14658por Kamran, Muhammad, Khalid, Abdullah B, Siddiqui, H. A. Basit, Aftab, Azib, Azmat, Rabeea“…Results The most common etiology was hepatitis C (52.3%, 46/88). The most common reason for intubation was airway protection (57.9%, 51/88). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14659por Barré, Tangui, Mercié, Patrick, Lions, Caroline, Miailhes, Patrick, Zucman, David, Aumaître, Hugues, Esterle, Laure, Sogni, Philippe, Carrieri, Patrizia, Salmon-Céron, Dominique, Marcellin, Fabienne“…BACKGROUND: Thanks to direct-acting antivirals, hepatitis C virus (HCV) infection can be cured, with similar rates in HCV-infected and HIV–HCV co-infected patients. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14660por Piratvisuth, Teerha, Tanwandee, Tawesak, Thongsawat, Satawat, Sukeepaisarnjaroen, Wattana, Esteban, Juan Ignacio, Bes, Marta, Köhler, Bruno, He, Ying, Swiatek‐de Lange, Magdalena, Morgenstern, David, Chan, Henry Lik‐Yuen“…Among all patients, 61.0% had hepatitis B, 32.9% had hepatitis C, and 60.5% had cirrhosis; 40.6% of patients with HCC had early stage cancer. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto